Table 2.
HLA-A*0201 native peptides and synthetic analogs
| Peptide | Sequence | Score a |
|---|---|---|
| P40–48 | TLFCQGLEVb | 257.34 |
| 1F3W6V7F | FLWCQVFEV | 15791.56 |
| 1Y6L7F | YLFCQLFEV | 15791.56 |
| 1Y6V7F | YLFCQVFEV | 15791.56 |
| 1Y3W7F | YLWCQGFEV | 15401.87 |
| 1Y7W | YLFCQGWEV | 8878.51 |
| 1F7F | FLFCQGFEV | 6865.90 |
| 1Y7F | YLFCQGFEV | 6865.90 |
| 1Y3W6L | YLWCQLLEV | 6107.64 |
| 1F3W6I | YLWCQILEV | 6107.64 |
| 1Y6V | YLFCQVLEV | 2722.68 |
| 7W | TLFCQGWEV | 1930.07 |
| 7F | TLFCQGFEV | 1492.59 |
| 1Y7Y | YLFCQGYEV | 1183.78 |
| 1F | FLFCQGLEV | 1183.78 |
| 1Y | YLFCQGLEV | 1183.78 |
| 1L | LLFCQGLEV | 437.48 |
| 7H | TLFCQGHEV | 257.34 |
Modifications from the native sequence are indicated in bold.
Abbreviation: hPEBP4, human phosphatidylethanolamine-binding protein 4.
aPropred-I prediction software available at http://crdd.osdd.net/raghava//propred1/.
bNative peptide derived from hPEBP4.